Elevance Health, Inc. $ELV Shares Sold by TD Asset Management Inc

TD Asset Management Inc reduced its position in Elevance Health, Inc. (NYSE:ELV) by 6.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 163,293 shares of the company’s stock after selling 11,285 shares during the quarter. TD Asset Management Inc owned about 0.07% of Elevance Health worth $57,242,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Rossby Financial LCC boosted its holdings in shares of Elevance Health by 110.0% in the third quarter. Rossby Financial LCC now owns 84 shares of the company’s stock valued at $28,000 after acquiring an additional 44 shares during the period. ORG Partners LLC boosted its holdings in shares of Elevance Health by 120.4% in the fourth quarter. ORG Partners LLC now owns 108 shares of the company’s stock valued at $38,000 after acquiring an additional 59 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in shares of Elevance Health in the fourth quarter valued at approximately $38,000. Dorato Capital Management acquired a new stake in shares of Elevance Health in the fourth quarter valued at approximately $41,000. Finally, Flagship Harbor Advisors LLC acquired a new stake in shares of Elevance Health in the fourth quarter valued at approximately $44,000. 89.24% of the stock is owned by institutional investors and hedge funds.

Elevance Health Price Performance

Elevance Health stock opened at $415.88 on Friday. Elevance Health, Inc. has a 12 month low of $273.71 and a 12 month high of $416.56. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.48 and a quick ratio of 1.48. The business has a 50 day simple moving average of $354.74 and a 200-day simple moving average of $341.76. The stock has a market capitalization of $90.31 billion, a PE ratio of 17.69, a price-to-earnings-growth ratio of 2.32 and a beta of 0.67.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $12.58 earnings per share for the quarter, topping analysts’ consensus estimates of $10.74 by $1.84. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The firm had revenue of $49.49 billion for the quarter, compared to analyst estimates of $48.21 billion. During the same quarter in the prior year, the company posted $11.97 earnings per share. Elevance Health’s quarterly revenue was up 1.5% on a year-over-year basis. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Equities analysts predict that Elevance Health, Inc. will post 26.94 earnings per share for the current year.

Elevance Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be given a $1.72 dividend. The ex-dividend date is Wednesday, June 10th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.7%. Elevance Health’s dividend payout ratio (DPR) is currently 29.26%.

Wall Street Analyst Weigh In

ELV has been the subject of several research analyst reports. The Goldman Sachs Group increased their price objective on Elevance Health from $350.00 to $370.00 and gave the company a “neutral” rating in a report on Friday, April 24th. Sanford C. Bernstein increased their price objective on Elevance Health from $384.00 to $424.00 and gave the company an “outperform” rating in a report on Friday, April 24th. Bank of America upped their price target on Elevance Health from $435.00 to $460.00 and gave the stock a “buy” rating in a research note on Thursday. Mizuho upped their price target on Elevance Health from $385.00 to $435.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 20th. Finally, Citigroup upgraded Elevance Health to a “buy” rating in a research note on Wednesday, April 29th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $411.11.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.